THE EFFECTS OF EARLY CANNABIS USE AND THE RISK OF SCHIZOPHRENIA: A NARRATIVE REVIEW
Keywords:
Marijuana, Schizophrenia, Genetic predisposition to diseaseAbstract
Objective: This article seeks to synthesize the scientific productions on the association between the harmful use of cannabis during adolescence and the risk of schizophrenia. Methods: This is a narrative review by searching the Scielo, Pepsic, PNAS and Pubmed databases. Original, review and gray literature articles in English, Spanish and Portuguese were included in the study. The selection of articles, national and international official documents covered the period from 2012 to 2022, excluding articles that did not fit the theme. Results: The main evidences support a neurobiological correlation between the problematic use of marijuana and the development of schizophrenia in individuals with genetic predisposition, indicating that there is an influence of genetic and environmental factors, since the chronic use of marijuana can precipitate the emergence of Schizophrenia in genetically vulnerable individuals. Final considerations: Although the evidence does not consider a causal relationship between the chronic use of cannabis and the onset of schizophrenia, it is now known that cannabis is a risk factor in this process.
Downloads
References
Barlow DH, Durand VM. Psicopatologia: Uma abordagem integrada. 7. ed. São Paulo: Cengage Learning; 2016.
Associação Americana De Psiquiatria – APA. Manual Diagnóstico e Estatístico de Transtornos Mentais – DSM-V. 5.ed. Trad. Maria Inês Corrêa Nascimento et al. Porto Alegre: Artmed, 2014.
Green AI, Tohen MF, Hamer RM, Strakowski SM, Lieberman JA, Glick I et al. First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol. Schizophr Res. 2004; 66(2-3):125-35.
Organização Mundial Da Saúde. Classificação Estatística Internacional de Doenças e Problemas Relacionados à Saúde. 10. ed. São Paulo: Editora da USP, 2012.
United Nations Office on Drugs and Crime. World Drug Report 2022. Nova York: United Nations Publication, Sales No. 22.XI.8, 2022.
Rother ET. Revisão sistemática x revisão narrativa. Acta Paul Enferm 2007; 20:v-vi.
Silva DAS, De Oliveira NR, Graça MS. A relação entre transtornos mentais e o uso de substâncias psicoativas. Ciência (In) Cena Bahia. 2018;1(6):38-50.
Carvalho MTVD. Canabinóides e o seu Prejuízo Mental: Psicoses e Doenças Psiquiátricas do tipo da Esquizofrenia. 2018. Dissertação (Mestrado Integrado em Medicina) - Universidade do Porto, Porto, 2018.
D'Souza DC, Radhakrishnan R, Sherif M, Cortes-Briones J, Cahill J, Gupta S et al. Cannabinoids and Psychosis. Curr Pharm Des. 2016;22(42):6380-6391.
Barrona, JIB. Psicose e Consumo de Canábis: Causa, Consequência ou Coincidência? 2017. Dissertação (Mestrado Integral em Medicina) - Universidade de Lisboa, Lisboa, 2017.
Van Der Pol P, Liebregts N, de Graaf R, Korf DJ, Van Den Brink W, Van Laar M. Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study. Drug Alcohol Depend. 2013;133(2):352-9.
Grotenhermen F, Muller-Vahl K. The therapeutic potential of cannabis and cannabinoids. Deutsches Arzteblatt International. 2012;109(29):495-501.
Gruber SA, Sagar KA, Dahlgren MK, Racine M, Lukas SE. Age of onset of marijuana use and executive function. Psychol Addict Behav. 2012;26(3):496-506.
Volkow ND, Wang GJ, Telang F, Fowler JS, Alexoff D, Logan J et al. Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity. The Proceedings of the National Academy of Sciences. 2014;111(30):149-156.
Yücel M, Lorenzetti V, Suo C, Zalesky A, Fornito A, Takagi MJ et al. Hippocampal harms, protection and recovery following regular cannabis use. Transl Psychiatry. 2016;6(1):e710.
Di Forti M, Sallis H, Allegri F, Trotta A, Ferraro L, Stilo AS et al. Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users. Schizophr Bull. 2014; 40(6):1509-17.
Myles H, Myles N, Large M. Cannanbis use in first episode psychosis: meta-analysis of prevalence, and the time course of initiation and continued use. Australasian and New Zealand Journal of Psychiatry. 2015; 50(3):208-219.
Di Forti M, Lyegbe C, Sallis H, Kolliakou A, Falcone MA, Paparelli A et al. Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users. Biol Psychiatry. 2012; 72(10):811-6.
Libuy N, Angel V, Ibáñez C. Risk of schizophrenia in marijuana users: Findings from a nationwide sample of drug users in Chile. | National Institute on Drug Abuse (NIDA), 2015.
Haney M, Evins AE. Does cannabis cause, exacerbate or ameliorate psychiatric disorders? An oversimplified debate discussed. Neuropsychopharmacology. 2016; 41(2):393-401.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Mariana Silva dos Santos, Fernanda de Moura Soares, Aline Santos Monte
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright
Submission of originals to Práticas e Cuidado: Revista de Saúde Coletiva (Practices and Care: Journal of Public Health - PC-RESC) implies the transfer of publication rights by the authors. The copyright for manuscripts published in this journal belongs to the authors, with PC-RESC retaining rights over the first publication. The authors may only use the same results in other publications if they explicitly indicate PC-RESC as the original publication medium.
Creative Commons License
Except where otherwise specified, the terms of a Creative Commons Attribution-ShareAlike 4.0 International License apply to the material published in this journal, which permits unrestricted use, distribution, and reproduction in any medium, provided the original publication is correctly cited.
This magazine is licensed under a License 